514 related articles for article (PubMed ID: 31990275)
21. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
Tosetto A; Rodeghiero F; Castaman G; Bernardi M; Bertoncello K; Goodeve A; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
J Thromb Haemost; 2007 Apr; 5(4):715-21. PubMed ID: 17408405
[TBL] [Abstract][Full Text] [Related]
22. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
[TBL] [Abstract][Full Text] [Related]
23. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
[TBL] [Abstract][Full Text] [Related]
24. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
[TBL] [Abstract][Full Text] [Related]
25. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder.
Othman M
Semin Thromb Hemost; 2011 Jul; 37(5):464-9. PubMed ID: 22102188
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of von Willebrand disease in Western Mexico.
Zavelia Padilla-Romo MG; Ornelas-Ricardo D; Luna-Záizar H; Rebeca Jaloma-Cruz A
Haemophilia; 2021 Jan; 27(1):e78-e87. PubMed ID: 33215800
[TBL] [Abstract][Full Text] [Related]
27. The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders.
Mehic D; Kraemmer D; Tolios A; Bücheler J; Quehenberger P; Haslacher H; Ay C; Pabinger I; Gebhart J
J Thromb Haemost; 2024 Jan; 22(1):101-111. PubMed ID: 37741511
[TBL] [Abstract][Full Text] [Related]
28. Von Willebrand disease type 2M: Correlation between genotype and phenotype.
Maas DPMSM; Atiq F; Blijlevens NMA; Brons PPT; Krouwel S; Laros-van Gorkom BAP; Leebeek FWG; Nieuwenhuizen L; Schoormans SCM; Simons A; Meijer D; van Heerde WL; Schols SEM
J Thromb Haemost; 2022 Feb; 20(2):316-327. PubMed ID: 34758185
[TBL] [Abstract][Full Text] [Related]
29. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
30. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M;
Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of type 2 von Willebrand disease.
Fressinaud E; Mazurier C; Meyer D
Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
[TBL] [Abstract][Full Text] [Related]
32. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
33. The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.
Flood VH; Garcia J; Haberichter SL
Curr Opin Hematol; 2019 Sep; 26(5):331-335. PubMed ID: 31261173
[TBL] [Abstract][Full Text] [Related]
34. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
[TBL] [Abstract][Full Text] [Related]
35. Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients.
Doshi BS; Rogers RS; Whitworth HB; Stabnick EA; Britton J; Butler RB; Obstfeld AE; Witmer CM
J Thromb Haemost; 2019 Nov; 17(11):1838-1847. PubMed ID: 31350816
[TBL] [Abstract][Full Text] [Related]
36. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
[TBL] [Abstract][Full Text] [Related]
37. Laboratory characterization of obligate carriers of type 3 von Willebrand disease with a potential role for Platelet Function Analyzer (PFA-200).
Geevar T; Dave RG; Mathews NS; Kumar S; Mammen JJ; Vijayan R; Aboobacker FN; Abraham A; Srivastava A; Nair SC
Int J Lab Hematol; 2022 Jun; 44(3):603-609. PubMed ID: 34986515
[TBL] [Abstract][Full Text] [Related]
38. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.
Eikenboom J; Van Marion V; Putter H; Goodeve A; Rodeghiero F; Castaman G; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
J Thromb Haemost; 2006 Apr; 4(4):774-82. PubMed ID: 16634746
[TBL] [Abstract][Full Text] [Related]
39. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
[TBL] [Abstract][Full Text] [Related]
40. Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.
Bucciarelli P; Siboni SM; Stufano F; Biguzzi E; Canciani MT; Baronciani L; Pagliari MT; La Marca S; Mistretta C; Rosendaal FR; Peyvandi F
J Thromb Haemost; 2015 Feb; 13(2):228-36. PubMed ID: 25425019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]